The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase Ib/II study of an anti-CD137 agonist antibody ADG106 in combination with weekly paclitaxel and dose-dense doxorubicin/cyclophosphamide.
 
Matilda Lee
Honoraria - Boehringer Ingelheim; Novartis
Consulting or Advisory Role - Boehringer Ingelheim
Travel, Accommodations, Expenses - Boehringer Ingelheim; Pfizer
 
Samuel Guan Wei Ow
Honoraria - AstraZeneca; DKSH; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; DKSH; Novartis; Pfizer; Roche
 
Andrea Wong
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; DKSH; Eisai; Pfizer
Research Funding - Otsuka
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo; DKSH; Eisai; Pfizer
 
Siew Eng Lim
No Relationships to Disclose
 
Joline Si Jing Lim
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; DKSH; Gilead Sciences; MSD; Novartis; Pfizer
Research Funding - CTI BioPharma Corp (Inst)
Travel, Accommodations, Expenses - AstraZeneca; MSD; Pfizer
 
Ross A. Soo
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; J INTS BIO; J INTS BIO; Lilly; Merck; Merck Serono; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Takeda; Yuhan
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; J INTS BIO; Janssen; Lilly; Merck; Merck Serono; Novartis; Pfizer; Puma Biotechnology; Roche/Genentech; Taiho Pharmaceutical; Takeda; Thermo Fisher Scientific; Yuhan
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Chee Cheng Ean
No Relationships to Disclose
 
David Shao Peng Tan
Leadership - Gynecological Cancer InterGroup
Stock and Other Ownership Interests - Asian Microbiome Library
Honoraria - AstraZeneca; Bayer; Boehringer Ingelheim; Eisai; Genmab; GlaxoSmithKline; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Boehringer Ingelheim; Eisai; Genmab; GlaxoSmithKline; MSD; Roche
Speakers' Bureau - AstraZeneca; Eisai; GlaxoSmithKline; Merck Serono; MSD; Roche; Takeda
Research Funding - AstraZeneca; Bayer; BerGenBio; Byondis; Eisai; GlaxoSmithKline; Karyopharm Therapeutics; Roche; Sutro Biopharma; Zeria Pharmaceutical
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Eisai; GlaxoSmithKline; Roche
 
Wei Peng Yong
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; DKSH; MSD; Novartis
Consulting or Advisory Role - Amgen; Astellas Pharma
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; DKSH; MSD; Novartis
Research Funding - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Experimental Drug Development Centre (EDDC)/A*STAR; MSD; Novartis; SCG Cell Therapy
 
Gloria Hui Jia Chan
No Relationships to Disclose
 
Jingshan Ho
No Relationships to Disclose
 
Kenneth Sooi
No Relationships to Disclose
 
Qin Jian Low
No Relationships to Disclose
 
Choon Seong Ang
No Relationships to Disclose
 
Seng Wee Cheo
No Relationships to Disclose
 
Raghav Sundar
Stock and Other Ownership Interests - Teladoc
Honoraria - Astellas Pharma; AstraZeneca; BeiGene; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; DKSH; Ipsen; Lilly; MSD; Roche; Taiho Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; DKSH; Eisai; GlaxoSmithKline; Merck; MSD; Novartis; Pierre Fabre; Taiho Pharmaceutical; Tavotek BioTherapeutics
Research Funding - CytoMed (Inst); CytoMed (Inst); MSD; Natera; Paxman
Patents, Royalties, Other Intellectual Property - Inventor on patent (pending): Method Of Predicting For Benefit From Immune Checkpoint Inhibition Therapy; Inventor on patent (pending): Portable Limb Compression System; Inventor on patent (pending): Wearable Limb Wraps for Temperature-Controlled Therapy
Travel, Accommodations, Expenses - AstraZeneca; CytoMed Therapeutics; DKSH; Eisai; Ipsen; Roche; Taiho Pharmaceutical
 
Boon C. Goh
Stock and Other Ownership Interests - Gilead Sciences; Regeneron; Seattle Genetics/Astellas; Seattle Genetics/Astellas
Honoraria - Amgen; MSD Oncology; Novartis
Consulting or Advisory Role - Adagene; Bayer; Novartis; Otsuka; Pfizer
Research Funding - Adagene (Inst); ALX Oncology (Inst); Bayer; Bristol-Myers Squibb/Medarex (Inst); Genentech/Roche; Kyowa Hakko Kirin; MSD Oncology (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Detection of biomarkers for NSCLC SG Patent no 10201811119X granted EU patent no 19894719.4 published 20 Oct 2021 Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression Patent Pending SG2021/050462; Detection of biomarkers for NSCLC SG Patent no 10201811119X granted EU patent no 19894719.4 published 20 Oct 2021 Modulation of Signal Transducer and Activator of Transcription 3 (STAT3) Expression Patent Pending SG2021/050462
 
Soo-Chin Lee
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Research Funding - Adagene; ASLAN Pharmaceuticals; Bayer; Eisai; Karyopharm Therapeutics; Pfizer; Taiho Pharmaceutical
Expert Testimony - Novartis
Travel, Accommodations, Expenses - ACT Genomics; AstraZeneca/MedImmune; Novartis; Pfizer; Roche